We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App




CT Scan Clot Detection System with Automated Algorithm Improves PE Diagnosis

By HospiMedica International staff writers
Posted on 05 Sep 2022
Print article
Image: Viz Aortic and Viz PE modules (Photo courtesy of Viz.ai, Inc.)
Image: Viz Aortic and Viz PE modules (Photo courtesy of Viz.ai, Inc.)

Detecting and coordinating the care of pulmonary embolism (PE) disease is challenging. This is especially true across large catchment areas with limited resources that rely on manual triage. Diagnosis and care coordination for patients suffering from PE requires fast multi-disciplinary communication for risk stratification and decision making. Now, an automated RV/LV ratio algorithm, which is seamlessly integrated into a deep learning solution to identify suspected central and segmental pulmonary emboli, flags key patient risk indicator of PE severity.

Viz.ai, Inc. (San Francisco, CA, USA) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an automated RV/LV ratio algorithm, a seamless new component of its Viz PE Solution. Launched in November 2021, Viz PE uses deep learning to identify suspected central and segmental pulmonary emboli in under two minutes. Delivered quickly to the entire care team on the Viz PE Solution, the information further enables care teams to ensure that the right clinical decision is made at the right time – no matter where the patient resides in the healthcare system – to ensure quick and appropriate care.

With the integration of the RV/LV algorithm, the Viz PE Solution now includes an automated assessment of potential right ventricle (RV) dilation. The algorithm is designed to quickly and accurately measure the diameter of the ventricles of the heart to provide the ratio of the maximum RV diameter versus that of the left ventricle (LV). Automating this key patient risk indicator will enable care teams to respond more quickly than before. The RV/LV ratio algorithm is another of the fast-growing number of FDA cleared AI algorithms on the enterprise-wide Viz Platform, which is clinically validated and proven to save time and improve patient outcomes and access to care across more than 1,200 health systems in the US and EMEA.

“The Viz.ai automated CT scan clot detection system improves diagnostic acumen and expedites care for patients with acute pulmonary embolism,” said Dr. Kenneth Rosenfield, Interventional Cardiologist, Section Head of Vascular Medicine and Intervention at Massachusetts General Hospital and Co-Founder of the PERT Consortium “But the true killer in patients with PE is failure of the right heart. With this clearance, the Viz PE Solution now includes both detection of clot in the lungs and degree of strain on the right heart. This will enable clinicians to quickly triage patients and treat them appropriately, by providing a powerful tool for early detection and risk stratification. This expedited critical decision-making will undoubtedly save lives.”

“With AI-powered enhanced image interpretation that dramatically improves the quality and speed of mobile image viewing – and caregiver communication – Viz PE already helps identify suspected pulmonary embolisms in under two minutes,” said Jayme Strauss, chief clinical officer, Viz.ai. “The addition of the RV/LV algorithm is expected to further aid care teams to quickly make the right clinical decision for their patients, improving outcomes and saving lives.”

Related Links:
Viz.ai, Inc.

BMP Whole Blood Analyzer: GEM Premier ChemSTAT
New
Gold Supplier
Blood Glucose Reference Analyzer
Nova Primary
New
Auto Liquid Handling & Homogenizer Workstation
LH 96
New
Calcitonin ELISA Test
Calcitonin AccuBind ELISA Test System

Print article
Radcal

Channels

AI

view channel
Image: AI transforms smartwatch ECG signals into a diagnostic tool for heart failure (Photo courtesy of Pexels)

AI-Based Smartwatch Accurately Detects Heart Failure Using ECG Signals

People with a weak heart pump might not have symptoms, but this common form of heart disease affects about 2% of the population and 9% of people over 60. When the heart cannot pump enough oxygen-rich blood,... Read more

Critical Care

view channel
Image: PATHFAST is a compact immunoanalyzer with superior assay performance (Photo courtesy of PHC Europe)

Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC

A compact immunoanalyzer with superior assay performance combines the accuracy of a full-scale lab analyzer with the flexibility of a mobile solution, making it an ideal analysis system for laboratories,... Read more

Surgical Techniques

view channel
Image: Bioelectric medicine could stem excessive blood loss (Photo courtesy of Pexels)

Wearable Neurostimulation Solution Could Stem Excessive Blood Loss in the OR

A wearable neurostimulation solution focused on lessening excessive blood loss could save precious time for surgical teams in the operating room. A collaboration between Spark Biomedical, Inc.... Read more

Patient Care

view channel
Image: The digital stretcher scales are designed specifically for emergent situations in hospitals and emergency rooms (Photo courtesy of DETECTO)

Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER

For emergency arrivals into a hospital, time is of the essence for gathering patient weights. Now, digital stretcher scales specifically designed for emergent situations in hospitals and emergency rooms... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Business

view channel
Image: The global visualization instruments for MIS market is estimated to surpass USD 21 billion by 2031 (Photo courtesy of Pexels)

Global Visualization Instruments for MIS Market Driven by Increasing Demand for Endoscopy Procedures

The last few years have witnessed an increase in patient preference for medical surgeries that involve fewer incisions. As a result, the demand for visualization instruments, which aid in achieving improved... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.